Events | GWG Satellite Events | What is Genome Engineering?

What is genome engineering? A special event for the science curious.

What is Genome Engineering? Where is it used? How do I benefit from it Should I care? We are exposed to terms like GMOs, genetic therapies, and gene editing. But what are these? Genome Engineer, Dr. Aron Geurts from the Medical College of Wisconsin will be addressing these questions. Afterwards, an ethicist will open a discussion about the how ethics do and should come into play in this pioneering field.

The event is free and open to the public. Everyone is welcome! This event is designed for a general audience to explain what these technologies are and how they are already playing a part in our lives. Coffee and refreshments will be served.

Where: Maudine Cow Room, Ohio Union,

1739 North High St., Columbus, OH 43210

When: 12:00 to 3:00 pm Saturday, March 31st, 2018

Questions: Contact AdamSychla at gmail.com
Adam Sychla and colleague in the front of the “Helix Wall” during the Genome Writers Guild 2017 meeting in Minneapolis, Minnesota. The mural was designed for the meeting by Lynn Fellman.

Adam Sychla and colleague in the front of the “Helix Wall” during the Genome Writers Guild 2017 meeting in Minneapolis, Minnesota. The mural was designed for the meeting by Lynn Fellman.


Dr. Aron Geurts, Speaker

Continuing research efforts in the Geurts lab are being driven by interests in developing genetic approaches for human health and disease.  For the past 12 years, Dr. Geurts has been developing tools for genetic manipulation in a variety of cell and animal systems including stem cells, zebrafish, mice, and laboratory rats. Dr. Geurts' creative and innovative contributions to the field of genetics and technology were recently recognized by the granting of a New Innovator Award. Dr. Geurts also serves as Guild Quaestor for the Genome Writers Guild and is an active member. 

Adam Sychla, Organizer

Adam Sychla is a fourth year Molecular Genetics and Physics major at the Ohio State University. As a Pelotonia Fellow, his research in Dr. Christin Burd's lab focuses on the regulation of an important tumor suppressor. He previously worked at the Mayo Clinic with Dr. Raymond Hickey developing a genetic therapy for Hereditary Tyrosinemia Type 1. He intends to attend graduate school with a focus in genetics next year. An active Guild Adept for the Genome Writers Guild, he has organized this dialogue as the first Guild event for the general public.